Group items tagged

Department of Health and Social Care (DHSC) has issued a medicine supply notification for GLP-1 receptor agonists used in the management of type 2 diabetes on Tuesday (27 June). "There are very limited, intermittent supplies of all glucagon-like peptide-1 receptor agonists (GLP-1 RAs) licensed in the management of Type 2 Diabetes Mellitus (T2DM)," said DHSC. The supply issues have been caused by an increase in demand for these products for licensed and off-label indications and it is not expected to return to normal until at least mid-2024. Pharmacists are urged to refer to the SPS Tool for Medicines Shortages for an up-to-date supply stock situation and clinical guidance on alternative treatment options.

Toothaches have various causes. Usually, they are the result of a cavity. Other reasons may be a broken tooth, a loose tooth, an infection or simply a piece of food that become wedged between teeth.

Herbal is one of the Best Ayurvedic formulations that helps in providing complete oral health. The herbal tooth paste is extremely beneficial for people.

Gum disease alone is a potential indicator of multiple severe heart conditions such as coronary artery disease. A recent study by AGD confirmed a correlation between gum disease and heart disease.

Our Office We are located on the southwest corner of Del Mar and Shaw Ave., between Blackstone and Maroa. The building is single story with a red tile roof, with plenty of parking in the back. 225 West Shaw Avenue, #103, Fresno, CA 93704 (559) 230-2300

Millions of people suffer from migraines daily. Migraines are severe headaches, pulsating on one side of the head. Symptoms vary from one person to another.

Toothbrushes have been around for thousands of years to clean teeth, but it has only been in recent decades it has evolved to offer strong protection against tooth decay.

Consumer healthcare group Haleon on Thursday announced that it has entered into a binding agreement for the sale of the ChapStick brand to Suave Brands Company, a company owned by American private equity firm Yellow Wood Partners. The British consumer healthcare company has agreed to sell its lip balm brand to Suave for about $430 million in cash and a minority interest in the buyer, valued at around $80 million. Haleon, which was spun off from the GSK Group in July 2022, said that cash proceeds from the sale would be used to pay down debt. ChapStick generated £112 million ($142.5 million) in revenue in 2023, said Haleon, adding that the sale is likely to close in the second quarter of 2024. Brian McNamara, Chief Executive Officer, Haleon, said: "Today's announcement is consistent with Haleon being proactive in managing our portfolio, and being rigorous and disciplined where there are opportunities for divestment. "While ChapStick is a great brand, much loved by consumers around the world, it is not a core focus for Haleon.